Primary Aldosteronsim, Pheochromocytoma/Paraganglioma, Cushing syndrome, subclinical Cushing syndrome, ACTH-Independent Macronodular Adrenal Hyperplasia (AIMAH), nonfunctioning adrenal tumor
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who were diagnosed as PA, pheochromocytoma/paraganglioma, Cushing syndrome, subclinical Cushing syndrome, ACTH-independent macronodular adrenal hyperplasia (AIMAH), and nonfunctioning adrenal tumor in Kyoto Medical Center and collaborated centers from Jan, 2006.
Exclusion criteria
Exclusion criteria: Patients who were judged not eligible for the study by respective attending physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) baseline informations(age, sex, duration of hypertension, family history, past history, comorbidity, medications, symptoms, height, weight, blood pressure, pulse rate), biochemical data, endocrine tests, Imaging 2) protocol and decision criteria of AVS 3) surgical and medical treatment 4) clinical outcomes | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)Pathological findings 2)Markers of target organ damage:Kidney(eGFR,BUN,Cr),Heart(ECG,CTR) 3)Clinical course(6M,1Y,3Y,5Y):base line information, Laboratory data 4)Imaging | — |
Countries
Japan,Asia(except Japan)
Contacts
National Hospital Organization, Kyoto Medical Center Adrenal Project, Clinical Research Institute for Endocrine and Metabolic Diseases